Number of COVID-19 infections continues to increase 1,329 new COVID-19 infections were reported over the past week. That is 342 more confirmed cases reported than the week before that, when 987 new COVID-19 infections were reported.
Number of COVID-19 infections is increasing 987 new COVID-19 infections were reported over the past week. This is nearly twice the number of infections reported in the previous week, when 534 new cases were reported.
Gap between intention and behaviour in staying home and testing for COVID-19 The Dutch policy of staying home and getting tested if you have corona-related symptoms can count on support from the majority of the over 50,000 participants in RIVM’s behavioural study.
About 100 COVID-19 infections detected per week through source and contact tracing The results of 14 days of monitoring of source and contact tracing are known for week 26 (22 to 28 June).
WHO Chemical Risk Assessment Workshop on new and emerging risks to human health from chemicals RIVM is hosting an international workshop on new and emerging risks from chemicals on 20 and 21 February 2019.
Possible health risks due to exposure to chromium-6 at tROM project Tilburg Research by RIVM shows that the participants in the so-called tROM project, their supervisors and other people involved may have been exposed to chromium-6.
Kick off European Project VITAL: Vaccines and InfecTious diseases in the Ageing popuLation Recently, the EU-sponsored Vaccines and InfecTious diseases in the Ageing popuLation (VITAL) project was launched.
Mental care still the most expensive of all In 2011, 19.6 billion euros was spent on the treatment of mental disorders. This amounted to 22% of the total expenditure on health and welfare during that year.
Risks of eHealth technology RIVM and Nictiz have made an overview of the risks that eHealth applications may entail and how these risks can be controlled.
Key organisations unite to improve benefit and risk assessments of vaccines Leading organisations have joined forces to launch a unique project that will pave the way for a pan-European framework for rapidly assessing and communicating the benefits and risks of vaccines.